SP-D and CC-16 Pneumoproteins' Kinetics and Their Predictive Role During SARS-CoV-2 Infection
Authors:
Open Access
- 8 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 761299
Abstract
Background: Surfactant protein D (SP-D) and pulmonary club cell protein 16 (CC-16) are called “pneumoproteins” and are involved in host defense against oxidative stress, inflammation, and viral outbreak. This study aimed to determine the predictive value of these pneumoproteins on the incidence of acute respiratory distress syndrome (ARDS) or death in patients with coronavirus disease-2019 (COVID-19).Methods: This retrospective study included 87 patients admitted to an emergency department. Blood samples were collected on three time points (days 1, 5, and 14 from hospital admission). SP-D and CC-16 serum levels were determined, and univariate and multivariate analyses considering confounding variables (age, body mass index, tobacco use, dyspnea, hypertension, diabetes mellitus, neutrophil-to-lymphocyte ratio) were performed.Results: Based on the multivariate analysis, SP-D level on D1 was positively and slightly correlated with subsequent development of ARDS, independent of body mass index, dyspnea, and diabetes mellitus. CC-16 level on D1 was modestly and positively correlated with fatal outcome. A rise in SP-D between D1 and D5 and D1 and D14 had a strong negative association with incidence of ARDS. These associations were independent of tobacco use and neutrophil-to-lymphocyte ratio.Conclusions: Overall, our data reveal that increase in SP-D levels is a good prognostic factor for patients with COVID-19, and that initial CC-16 levels correlated with slightly higher risk of death. SP-D and CC-16 may prove useful to predict outcomes in patients with COVID-19.Keywords
This publication has 58 references indexed in Scilit:
- An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive ImmunityFrontiers in Immunology, 2012
- Respiratory effects associated with wood fuel use: A cross‐sectional biomarker study among adolescentsPediatric Pulmonology, 2011
- Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patientsBMC Pulmonary Medicine, 2010
- Clara Cell Protein (CC16), a Marker of Lung Epithelial Injury, Is Decreased in Plasma and Pulmonary Edema Fluid From Patients With Acute Lung InjuryChest, 2009
- Elevated Plasma Surfactant Protein D (SP‐D) Levels and a Direct Correlation with Anti‐severe Acute Respiratory Syndrome Coronavirus‐specific IgG Antibody in SARS PatientsScandinavian Journal of Immunology, 2009
- Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohortThorax, 2008
- Surfactant protein A and surfactant protein D variation in pulmonary diseaseImmunobiology, 2007
- The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophagesImmunobiology, 2007
- Serum CC-10 in Inflammatory Lung DiseasesRespiration, 2004
- Immunological functions of the pulmonary epitheliumEuropean Respiratory Journal, 1995